Infectious Disease Diagnostics Market Booming Worldwide with Latest Trend and Future Scope by 2029

Infectious disease diagnostics market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Infectious diseases are diseases caused by microscopic organisms including bacteria, viruses, parasites, and fungi. The organisms enter the body, multiply and cause symptoms ranging from mild to severe, including death. According to WHO, At least 169 severe hepatitis cases have been identified in children in an outbreak that involves 12 countries. Further in July 2022, WHO declared monkeypox a global health emergency. Climate change, rapid urbanization, globalnisation, and the rising burden of infectious diseases and hospital acquired infections are primary factors driving the market growth of the infectious disease diagnostics market. The shift from centralized laboratories towards decentarlised point of care testing due to delay in results, high cost of tests, and late disease diagnosis is also an important factor anticipated to propel the demand for infectious disease diagnostics during the forecast period. Also, Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to drive the market growth in forecast period. For instance, in August 2022, the Australian Government funded $5.2 million to strengthen laboratory capacity for testing and diagnosis of COVID-19, HIV, malaria and tuberculosis in the Indo-Pacific region.

The global infectious disease diagnostics market is segmented based on the product & solution, technology, disease type, and end-user. Based on the product & solution, the market is segmented into consumables, instruments, and software & services. Based on the technology, the market is sub-segmented into the immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing (NGS), DNA microarray technology, and other technologies. Based on the disease type, the market is sub-segmented into the hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), Human, papillomavirus (HPV), tuberculosis (TB), influenza and other diseases. Based on the End-User, the market is sub-segmented into the hospital/clinical laboratories, reference laboratories, academics/research institutes, and others. Among product & solution, the consumables sub-segment is anticipated to hold the dominant share in the market.

To Request a Sample of our Report on Infectious Disease Diagnostics Market:  https://www.omrglobal.com/request-sample/infectious-disease-diagnostics-market

Infectious Disease Diagnostics Market Segmentation

By Product & Solution

Consumables
Instruments
Software & Services

By Technology

Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology 
DNA Sequencing and Next-Generation Sequencing (NGS) 
DNA Microarray Technology 
Other technologies 
(Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification)

By Disease Type

Hepatitis
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV) 
Tuberculosis (TB) 
Influenza 
Other Diseases (measles, smallpox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough)

By End-User

Hospital/Clinical Laboratories
Reference Laboratories
Academics/Research Institutes
Others

A full Report of Infectious Disease Diagnostics Market is Available @ https://www.omrglobal.com/industry-reports/infectious-disease-diagnostics-market

Regional Analysis           

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Company Profiles 

Becton, Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
Chembio Diagnostic Systems
Danaher Corp. 
DiaSorin S.p.A.
ELITech Group
Genetic Signatures Ltd. 
Grifols S.A.
Hologic, Inc.
Meridian Bioscience Inc.
Meril Life Sciences Pvt. Ltd.
Clinical Diagnostics Holdings plc
QIAGEN N.V. 
Quidel Corp. 
Seegene, Inc. 
Sysmex Corp.
Trinity Biotech Plc.

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/infectious-disease-diagnostics-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.